Shepherd Street Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Shepherd Street Advisors's VRTX Position: Q2 2026 in Review
Shepherd Street Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, selling an estimated $22.2K and leaving 3,168 shares worth $1.51M. The position accounts for 1.33% of the portfolio, ranked #26.
Shepherd Street Advisors first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,752 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Shepherd Street Advisors held 3,168 shares of Vertex Pharmaceuticals worth $1.51M as of Q2 2026.
- Shepherd Street Advisors sold 50 Vertex Pharmaceuticals shares in Q2 2026, an estimated $22.2K.
- Vertex Pharmaceuticals made up 1.33% of Shepherd Street Advisors's portfolio in Q2 2026, its #26 holding.
- Shepherd Street Advisors first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,752 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Shepherd Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.